XIENCE V Official Site

Magnetic Resonance Imaging (MRI) and Intracoronary Stents

Additional information about the safety of performing MRI following the placement of a XIENCE V Everolimus Eluting Coronary Stent.

Metal Allergy Testing

Information regarding allergy testing for 316L stainless steel and L605 cobalt chromium

Rubber Latex - XIENCE V Everolimus Eluting Coronary Stent

Letter addressing latex materials and the XIENCE V Everolimus Eluting Coronary Stent.

Cobalt Chromium - XIENCE V Everolimus Eluting Coronary Stent

Information about XIENCE V's cobalt chromium alloy, including ultra-low nickel content.

Polyvinyl Chloride (PVC) - XIENCE V Everolimus Eluting Coronary Stent

Letter explaining that Abbott Vascular products do not contain polyvinyl chloride.

* XIENCE V has demonstrated statistical superiority in the primary endpoints of SPIRIT IV, SPIRIT III and SPIRIT II in target lesion failure, in-segment late loss and in-stent late loss respectively. Source: SPIRIT IV 1-year results, Gregg Stone, TCT 2009 and XIENCE V IFU. TAXUS Express was the control in SPIRIT IV.

AP2931129 Rev. A

Site Map | International Terms of Use | International Privacy Policy | Contact Us

All illustrations are artist’s renditions.

Unless otherwise specified, all product names appearing in this Internet site are trademarks owned by or licensed to Abbott Laboratories, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott Laboratories, except to identify the product or services of the company.